France· FR:66085510
NIFLURIL 250 mg, gélule
A medicinal product containing acide niflumique, registered in France by UPSA, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ACIDE NIFLUMIQUE
- Manufacturer
- UPSA
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009307287963 plaquette(s) thermoformée(s) PVC aluminium de 10 gélule(s)EUR 2.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acide niflumique in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Niflugel
- Spain · Niflactol
- Greece · Niflamol
- Hungary · Donalgin
- Italy · Niflam
- Luxembourg · Niflugel
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a4f2d6a5-efed-416c-a8e1-3df4b0cfdc34 GET /v1/drugs/a4f2d6a5-efed-416c-a8e1-3df4b0cfdc34?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66085510",
"date_amm": "1996-07-15",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "ACIDE NIFLUMIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about acide niflumique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.